You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Linker

Showing 1 - 25 of 155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Relapsed Refractory Multiple Myeloma
  • (no location specified)
Feb 6, 2023

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

Total Knee Arthroplasty Trial (Mobility Tool)

Not yet recruiting
  • Total Knee Arthroplasty
  • Mobility Tool
  • (no location specified)
Oct 5, 2023

Solid Tumor Trial in Durham (HS-196)

Suspended
  • Solid Tumor
  • Durham, North Carolina
    Duke University Medical Center
Dec 19, 2022

Advanced Cancer Trial in Guangzhou (TQB2102 injection)

Not yet recruiting
  • Advanced Cancer
  • TQB2102 injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 23, 2023

Solid Tumor Trial in Brussels, Bordeaux, Lille (SYD1875)

Active, not recruiting
  • Solid Tumor
  • Brussels, Belgium
  • +2 more
Jan 12, 2022

Diabetes, Type 2 Trial in Leuven (The EBMeDS system, Evidence Linker)

Completed
  • Diabetes Mellitus, Type 2
  • The EBMeDS system
  • Evidence Linker
  • Leuven, Vlaams-Brabant, Belgium
    Katholieke Universiteit Leuven
Jul 15, 2019

HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)

Not yet recruiting
  • HER2
  • Colorectal Cancer
  • Disitamab Vedotin Combined With Fruquintinib
  • (no location specified)
Dec 21, 2022

Acute Myeloid Leukemia Trial in Canada, United States (ASP1235)

Terminated
  • Acute Myeloid Leukemia
  • Duarte, California
  • +6 more
Oct 28, 2021

Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))

Recruiting
  • Ovarian Cancer
  • +2 more
  • mirvetuximab soravtansine (MIRV; IMGN853)
  • Birmingham, Alabama
    University of Alabama at Birmingham Womens & Infants Center
Jun 30, 2022

Solid Tumor Trial (BB-1705)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
May 16, 2022

Advanced Solid Tumor Trial in United States (CLN-617, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +5 more
Sep 12, 2023

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
May 30, 2023

Healthy Trial in Berlin (Slow sodium tablets)

Completed
  • Healthy
  • Slow sodium tablets
  • Berlin, Germany
    Experimental & Clinical Research Center
Jul 7, 2022

Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 12, 2023

Breast Cancer Trial in Spain (U3 1402)

Recruiting
  • Breast Cancer
  • U3 1402
  • Badalona, Barcelona, Spain
  • +9 more
Apr 1, 2022

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

Acute Myeloid Leukemia, MDS Trial (SPRX002, ARC-T)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • SPRX002
  • ARC-T
  • (no location specified)
Jul 12, 2022

NSCLC (NSCLC) Trial in Worldwide (U3-1402 (FL-DP), U3-1402 (CTM-1 Lyo-DP), U3-1402 (CTM-3 Lyo-DP))

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • U3-1402 (FL-DP)
  • +2 more
  • Duarte, California
  • +21 more
Jul 5, 2022

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Advanced Malignant Tumor Trial in China (TQB2103 for injection)

Not yet recruiting
  • Advanced Malignant Neoplasm
  • TQB2103 for injection
  • Zhengzhou, Henan, China
  • +3 more
May 19, 2023

Breast Cancer Trial (Disitamab Vedotin+Anlotinib)

Not yet recruiting
  • Breast Cancer
  • Disitamab Vedotin+Anlotinib
  • (no location specified)
Aug 14, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Austria, Germany (Glofitamab, Rituximab, Obinutuzumab)

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Linz, Austria
  • +17 more
Mar 22, 2023

Solid Tumor Trial in Worldwide (BYON3521)

Recruiting
  • Solid Tumor
  • Brussels, Belgium
  • +3 more
Aug 2, 2022

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023